← Feed

Lin Shao-Lee

SEC Form 4 insider
Chief Executive Officer · Cue Biopharma, Inc. ($CUE)
1 thesis · first seen Aug 15, 2026
WindowThesesResolvedWinsWin rateAvg returnMedian return
1d——————
3d——————
1w——————
1m——————
3m——————
6m——————
1y——————

Past performance does not predict future results. Informational only, not investment advice.

Thesis history

$CUESEC Form 4bearish
Lin Shao-Lee · Chief Executive Officer at Cue Biopharma, Inc. · 3h agono track record yet
Sold 58,258 @ $27.58 avg · $1,606,562 · 2026-08-12

Form 4: Lin Shao-Lee sold CUE

Lin Shao-Lee (Chief Executive Officer at Cue Biopharma, Inc.) reported an open-market sale of 58,258 shares of CUE at an average $27.58, roughly $1,606,562, in a Form 4 filed 2026-08-14.

View filing on SEC.gov →

End of results.